Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03746158 · ClinicalTrials.gov registry record · NA
Interindividual Variation in Excretion of Curcumin
A NA study, sponsored by University of Massachusetts, Amherst.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03746158 is a NA study that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 8 participants.
The verdict
NCT03746158, a NA study, has completed, sponsored by University of Massachusetts, Amherst.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The objective of this project is to elucidate the interindividual variations in excretion of curcumin and its metabolites.
Interventions
- DIETARY_SUPPLEMENT curcumin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2019-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03746158
The ClinicalTrials.gov registry entry for NCT03746158 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Amherst, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which curcumin is the first listed.
NCT03746158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03746158 about?
NCT03746158 is a clinical study titled "Interindividual Variation in Excretion of Curcumin". The objective of this project is to elucidate the interindividual variations in excretion of curcumin and its metabolites.
What is the current status of trial NCT03746158?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2018-09-01. Estimated completion is 2019-10-01.
What interventions are being tested in trial NCT03746158?
The interventions under investigation include: curcumin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03746158?
This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.